Arrow Financial’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $574K | Sell |
6,739
-150
| -2% | -$13.4K | 0.06% | 121 |
|
|
2025
Q4 | $544K | Sell |
6,889
-835
| -11% | -$65.5K | 0.05% | 124 |
|
|
2025
Q3 | $617K | Hold |
7,724
| – | – | 0.06% | 115 |
|
|
2025
Q2 | $702K | Sell |
7,724
-33
| -0.4% | -$3.01K | 0.07% | 112 |
|
|
2025
Q1 | $727K | Hold |
7,757
| – | – | 0.08% | 107 |
|
|
2024
Q4 | $705K | Sell |
7,757
-432
| -5% | -$41.2K | 0.07% | 120 |
|
|
2024
Q3 | $850K | Sell |
8,189
-35
| -0.4% | -$3.57K | 0.08% | 115 |
|
|
2024
Q2 | $798K | Sell |
8,224
-85
| -1% | -$7.84K | 0.08% | 114 |
|
|
2024
Q1 | $748K | Sell |
8,309
-172
| -2% | -$14.6K | 0.07% | 115 |
|
|
2023
Q4 | $676K | Sell |
8,481
-411
| -5% | -$30.9K | 0.07% | 120 |
|
|
2023
Q3 | $632K | Buy |
8,892
+134
| +2% | +$10K | 0.07% | 115 |
|
|
2023
Q2 | $675K | Sell |
8,758
-282
| -3% | -$21.8K | 0.08% | 117 |
|
|
2023
Q1 | $679K | Hold |
9,040
| – | – | 0.09% | 120 |
|
|
2022
Q4 | $713K | Sell |
9,040
-170
| -2% | -$12.7K | 0.1% | 118 |
|
|
2022
Q3 | $646K | Hold |
9,210
| – | – | 0.09% | 119 |
|
|
2022
Q2 | $738K | Sell |
9,210
-100
| -1% | -$7.82K | 0.1% | 115 |
|
|
2022
Q1 | $706K | Buy |
9,310
+9
| +0.1% | +$713 | 0.08% | 125 |
|
|
2021
Q4 | $793K | Sell |
9,301
-400
| -4% | -$31.2K | 0.09% | 115 |
|
|
2021
Q3 | $733K | Hold |
9,701
| – | – | 0.09% | 121 |
|
|
2021
Q2 | $790K | Sell |
9,701
-78
| -0.8% | -$6.38K | 0.1% | 119 |
|
|
2021
Q1 | $771K | Sell |
9,779
-225
| -2% | -$17.6K | 0.1% | 121 |
|
|
2020
Q4 | $856K | Hold |
10,004
| – | – | 0.17% | 95 |
|
|
2020
Q3 | $771K | Sell |
10,004
-240
| -2% | -$18.3K | 0.16% | 101 |
|
|
2020
Q2 | $750K | Sell |
10,244
-225
| -2% | -$16K | 0.16% | 100 |
|
|
2020
Q1 | $695K | Sell |
10,469
-515
| -5% | -$36.3K | 0.16% | 98 |
|
|
2019
Q4 | $756K | Sell |
10,984
-1,588
| -13% | -$108K | 0.15% | 104 |
|
|
2019
Q3 | $924K | Sell |
12,572
-545
| -4% | -$39.5K | 0.19% | 96 |
|
|
2019
Q2 | $940K | Buy |
13,117
+125
| +1% | +$8.87K | 0.2% | 96 |
|
|
2019
Q1 | $890K | Sell |
12,992
-160
| -1% | -$10.3K | 0.21% | 96 |
|
|
2018
Q4 | $784K | Sell |
13,152
-180
| -1% | -$11.3K | 0.2% | 99 |
|
|
2018
Q3 | $892K | Sell |
13,332
-100
| -0.7% | -$6.66K | 0.19% | 102 |
|
|
2018
Q2 | $870K | Sell |
13,432
-360
| -3% | -$23.5K | 0.2% | 102 |
|
|
2018
Q1 | $989K | Sell |
13,792
-105
| -0.8% | -$7.56K | 0.23% | 95 |
|
|
2017
Q4 | $1.05M | Buy |
13,897
+55
| +0.4% | +$4.02K | 0.24% | 90 |
|
|
2017
Q3 | $1.01M | Buy |
13,842
+35
| +0.3% | +$2.52K | 0.24% | 90 |
|
|
2017
Q2 | $1.02M | Sell |
13,807
-113
| -0.8% | -$8.39K | 0.24% | 96 |
|
|
2017
Q1 | $1.02M | Sell |
13,920
-170
| -1% | -$11.9K | 0.25% | 96 |
|
|
2016
Q4 | $922K | Sell |
14,090
-365
| -3% | -$25K | 0.23% | 97 |
|
|
2016
Q3 | $1.07M | Sell |
14,455
-850
| -6% | -$62.8K | 0.27% | 92 |
|
|
2016
Q2 | $1.12M | Sell |
15,305
-1,313
| -8% | -$93.5K | 0.29% | 89 |
|
|
2016
Q1 | $1.17M | Sell |
16,618
-1,771
| -10% | -$118K | 0.31% | 83 |
|
|
2015
Q4 | $1.23M | Sell |
18,389
-15,159
| -45% | -$1.01M | 0.33% | 82 |
|
|
2015
Q3 | $2.13M | Sell |
33,548
-240
| -0.7% | -$15.7K | 0.61% | 57 |
|
|
2015
Q2 | $2.21M | Sell |
33,788
-4,707
| -12% | -$319K | 0.6% | 56 |
|
|
2015
Q1 | $2.67M | Sell |
38,495
-3,975
| -9% | -$275K | 0.72% | 43 |
|
|
2014
Q4 | $2.94M | Sell |
42,470
-2,980
| -7% | -$201K | 0.8% | 42 |
|
|
2014
Q3 | $2.96M | Sell |
45,450
-7,930
| -15% | -$523K | 0.82% | 38 |
|
|
2014
Q2 | $3.64M | Sell |
53,380
-335
| -0.6% | -$22.5K | 0.98% | 24 |
|
|
2014
Q1 | $3.49M | Sell |
53,715
-1,405
| -3% | -$88.5K | 0.99% | 23 |
|
|
2013
Q4 | $3.59M | Buy |
55,120
+335
| +0.6% | +$21.4K | 1.03% | 21 |
|
|
2013
Q3 | $3.25M | Buy |
54,785
+270
| +0.5% | +$16K | 1% | 23 |
|
|
2013
Q2 | $3.12M | Buy |
+54,515
| New | +$3.24M | 1% | 27 |
|
Other funds holding CL
VCM
DAM
VPM
Arrow Financial's CL Position: Q1 2026 in Review
Arrow Financial reduced its Colgate-Palmolive (CL) stake by 2.2% in Q1 2026, selling an estimated $13.4K and leaving 6,739 shares worth $574K. The position accounts for 0.06% of the portfolio, ranked #121.
Arrow Financial first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.64M in Q2 2014. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Arrow Financial held 6,739 shares of Colgate-Palmolive worth $574K as of Q1 2026.
- Arrow Financial sold 150 Colgate-Palmolive shares in Q1 2026, an estimated $13.4K.
- Colgate-Palmolive made up 0.06% of Arrow Financial's portfolio in Q1 2026, its #121 holding.
- Arrow Financial first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
- Arrow Financial's Colgate-Palmolive position peaked at $3.64M in Q2 2014.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Arrow Financial's 13F filing for Q1 2026, filed 11 May 2026.